Reviva Pharmaceuticals Holdings, Inc. (RVPH) Social Stream
REVIVA PHARMACEUTICALS HOLDINGS INC (RVPH) Price Targets From Analysts
Use the tables below to see what analysts covering REVIVA PHARMACEUTICALS HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-24 | 1 | $19 | $10 | $14.5 | $5.23 | 177.25% |
| 2022-01-11 | 1 | $16 | $10 | $13 | $5.23 | 148.57% |
| 2022-03-17 | 2 | $16 | $10 | $12 | $5.23 | 129.45% |
| 2022-05-19 | 2 | $16 | $5 | $10.333 | $5.23 | 97.57% |
| 2022-08-19 | 2 | $16 | $3 | $9.666 | $5.23 | 84.82% |
| 2022-11-18 | 2 | $16 | $10 | $14 | $5.23 | 167.69% |
| 2023-04-04 | 2 | $16 | $10 | $13 | $5.23 | 148.57% |
| 2023-06-02 | 2 | $18 | $10 | $15 | $5.23 | 186.81% |
| 2023-08-18 | 3 | $18 | $10 | $15.4 | $5.23 | 194.46% |
The Trend in the Analyst Price Target
RVPH's average price target has moved up $0.9 over the prior 24 months.
Over the past 41 weeks, RVPH's average upside potential has been 175.53%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-17 | 2 | 16 | 10 | 13.0 | 4.25 | 205.88% |
| 2023-03-10 | 2 | 16 | 10 | 13.0 | 4.41 | 194.78% |
| 2023-05-08 | 2 | 18 | 10 | 15.0 | 8.36 | 79.43% |
| 2023-05-17 | 2 | 18 | 10 | 15.0 | 7.98 | 87.97% |
| 2023-06-08 | 3 | 18 | 10 | 15.4 | 7.15 | 115.38% |
RVPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
RVPH's average broker recommendation rating improved by 0 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how REVIVA PHARMACEUTICALS HOLDINGS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 26.37% of that group.
- REVIVA PHARMACEUTICALS HOLDINGS INC's average analyst price target is greater than 148.76% of all US stocks.
- In terms of how REVIVA PHARMACEUTICALS HOLDINGS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 805.49% of that group.
- REVIVA PHARMACEUTICALS HOLDINGS INC's variance in analysts' estimates is lower than -635.58% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REVIVA PHARMACEUTICALS HOLDINGS INC are VCNX, ADIL, and XCUR.
View All Top Stocks by Price Target
What is the outlook for RVPH? Use POWR Ratings for clearer insight into price direction.